BioTech healthcare technology Leadership 
Healthcare IT Today
OCTOBER 24, 2024
. “Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.” MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.
Lloyd Price
MARCH 1, 2025
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. in 2023 but still higher than the average revenue multiple for all technology companies, which is 3.5x. What are the biggest trends likely to affect healthcare technology multiples in 2025?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
FEBRUARY 23, 2025
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.
Digital Health Global
JUNE 20, 2023
With the additional funding and board appointments, we are set to accelerate the validation of our approach by advancing multiple programs and partnerships toward the ultimate test of any biopharma technology platform – human clinical trials.” Jane Rhodes, Ph.D., Jane Rhodes, Ph.D., Bernd Seizinger, M.D., and Europe.
Lloyd Price
DECEMBER 2, 2024
By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Digital Health Global
AUGUST 2, 2023
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.
Digital Health Global
MARCH 2, 2023
Our engagement over the past year in scaling and expanding Koneksa’s medical function, under the leadership of Koneksa Chief Medical Officer Dr. John Wagner, has confirmed that our interests are highly aligned, and we look forward to this next phase of growth.”
Expert insights. Personalized for you.
124 
Let's personalize your content